11月7日uSMART交易熱榜 | 特斯拉創52周新低,商湯暴漲35%首度上榜
11月7日uSMART交易熱度排行榜

週一(7日)港美股紛紛上漲,港股進入11月以來絕地反擊,而美股在中期選舉前實現2連漲,整體來看投資者的方向不是非常明確,多空ETF的交易熱度都比較靠前。美股方面,TQQQ、SQQQ熱度依舊排在前3,港股方面7552、7200、7226也都上榜。
個股方面,特斯拉排熱度榜第1,週一逆市大跌5%,股價創52周新低,自馬斯克高調宣佈收購推特後,特斯拉股價一直承壓。
港股明星個股中除了騰訊、阿裏巴巴、小米,商湯也首次上榜,商湯週一暴漲35%,主要是受益於行業的利好政策。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.